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Tuesday, July 5, 2022
During this COVID-19 pandemic and other future events, the CDM has been and will continue
to be a source of reliable information, education and models for mitigation, preparedness,
response, and recovery. We hope this informational document has helped provide you
filtered and actionable information. As the pace of new information and changes occur, we
will evaluate the current once per week to determine if this information should be provided on
a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics

Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

549,772,831

6,339,843

11,767,549,228

United States

87,880,693

1,017,904

592,765,023

New Jersey

2,500,418

34,065

17,737,437

New York

5,625,004

69,698

40,331,482

Connecticut

833,260

11,045

7,871,672

Information as of 7/4/22 at 2000 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
•
•
•
•
•

Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continue to partner with local organizations such as Westchester Department of Emergency
Services and Westchester Medical Center to ensure ongoing collaboration with all public
safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.

•
•
•
•

Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.
On June 29, 2022, the Center for Disaster Medicine provided PreHospital Trauma Life
Support (PHTLS) to various agencies from the Hudson Valley region including Scarsdale
Volunteer Ambulance Corps, Empress EMS and Valhalla Volunteer Ambulance Corps.
Ongoing emergency training is critical because medical emergencies continue to occur even
during a pandemic.

The White House
On June 30, 2022, President Biden provided statement on Pandemic Preparedness, Prevention
and Response Fund at the World Bank- the World Bank Board voted to approve the
establishment of a new Financial Intermediary Fund that will make the world safer and more
secure from pandemics.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/06/30/statement-bypresident-biden-on-pandemic-preparedness-prevention-and-response-fund-at-the-world-bank/
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic, provide
economic relief, tackle climate change, and advance racial equity and civil rights, as well as
immediate actions to reform our immigration system and restore America’s standing in the world.
This website will provide all information in one central location.
https://www.whitehouse.gov
COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website
was launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/
Health and Human Services (HHS)
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html
National Institutes of Health (NIH)
On June 29, 2022, NIH announced NIH-funded project offers efficient approach when tracking
SARS-CoV-2 variants- An interdisciplinary research team has developed a fast, cost-effective
method to detect the circulation of SARS-CoV-2 variants. SARS-CoV-2 is the virus that causes
COVID-19. The team, funded by the National Institutes of Health’s Rapid Acceleration of
Diagnostics (RADx®) Tech program, adopted a customizable genotyping approach to identify
known variants and subvariants. The approach can augment current surveillance methods that
use comprehensive next-generation sequencing of virus samples, helping focus sequencing
efforts on samples representing unknown and emerging variants.
https://www.nih.gov/news-events/news-releases/nih-funded-project-offers-efficient-approachwhen-tracking-sars-cov-2-variants
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
On July 1, 2022, 438 tests and sample collection devices are authorized by the FDA
under emergency use authorizations (EUAs). These include 303 molecular tests and
sample collection devices, 85 antibody and other immune response tests, 49 antigen
tests, and 1 diagnostic breath test. There are 80 molecular authorizations and 1 antibody
authorization that can be used with home-collected samples. There is 1 EUA for a
molecular prescription at-home test, 2 EUAs for antigen prescription at-home tests, 17
EUAs for antigen over-the-counter (OTC) at-home tests, and 3 for molecular OTC athome tests. The FDA has authorized 27 antigen tests and 8 molecular tests for serial
screening programs. The FDA has also authorized 1021 revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-july-1-2022
On June 30, 2022, FDA Recommends Inclusion of Omicron BA.4/5 Component for
COVID-19 Vaccine Booster Doses- the U.S. Food and Drug Administration’s independent
experts on the Vaccines and Related Biological Products Advisory Committee met to
publicly discuss whether a change to the current vaccine strain composition of COVID-19
vaccines for booster doses is necessary for the 2022 fall and winter seasons.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fdarecommends-inclusion-omicron-ba45-component-covid-19-vaccine-booster
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19
Centers for Disease Control and Prevention (CDC)
On July 1, 2022, the CDC provided Interim Recommendations of the Advisory Committee
on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines
in Children Aged 6 Months–5 Years — United States, June 2022.
https://www.cdc.gov/mmwr/volumes/71/wr/mm7126e2.htm?s_cid=mm7126e2_x
On July 1, 2022, the CDC provided updated guidance regarding COVID-19 during
pregnancy including that:
•

•

People who are pregnant or recently pregnant are more likely to get very sick
from COVID-19 compared to people who are not pregnant.
o Severe illness includes illness that may require admission to an intensive
care unit (ICU), ventilation, extracorporeal membrane oxygenation
(ECMO, an advanced life support technique used for patients with lifethreatening heart and/or lung problems) and may even result in death.
People who have COVID-19 during pregnancy are also at increased risk for
complications that can affect their pregnancy and developing baby. For example,
COVID-19 during pregnancy increases the risk of delivering a preterm (earlier
than 37 weeks) and/or a stillborn infant.

The emergence of the Delta variant in June of 2021 was associated with an even
greater risk for severe outcomes for pregnant people, including an increase in
ICU admissions, an increase in required medical interventions such as invasive
ventilation and ECMO, and an increased number of deaths than was previously
reported in the pre-Delta period (January 1, 2020 – June 26, 2021).
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/specialpopulations/pregnancy-data-on-covid-19/what-cdc-is-doing.html
•

On June 30, 2022, the CDC provided guidance on Global Community Mitigation.
https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/global-communitymitigation.html
CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the
characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html
Center for Medicare and Medicaid Services (CMS) +
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page
Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of July 5, 2022, the FDA has granted Emergency Use
Authorization (EUA) to Janssen/Johnson & Johnson for adults over 18 years and EUA for
Moderna and Pfizer for children 6 months to five years. On August 23, 2021, the FDA
granted full approval to Pfizer for adults. On January 31, 2022, the FDA granted full
approval to Moderna for adults. Now with two vaccines with full FDA approval and one
vaccine with EUA for adults and children, the goal is to vaccinate a larger number of
persons in the coming months throughout the United States. As additional vaccines are
granted EUA, information for those vaccines will also be included.

On June 24, 2022, the CDC Recommended Moderna COVID-19 Vaccine for Children and
Adolescents. CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC
Advisory Committee on Immunization Practices’ (ACIP) recommendation that Moderna’s
COVID-19 vaccine be used as an option for children ages 6 through 17 years, in addition
to its already recommended use in children 6 months through 5 years and adults 18 years
and older. This recommendation reinforces the use of Moderna’s COVID-19 vaccine as
an important tool in the pandemic and provides another vaccine option for children and
adolescents. The ACIP recommendation comes after a thorough review of the scientific
evidence demonstrating safety and efficacy, and supports the use of the vaccine among
those 6 through 17 years of age.
https://www.cdc.gov/media/releases/2022/s0623-moderna-children.html
CDC created this section regarding COVID-19 vaccinations in the United States- CDC
provides overall U.S. COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 p.m. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works. As of January 31, 2022, the fully FDA
approved Moderna vaccine will now be known as SPIKEVAX for ages 6 months and
older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 6 months and
older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine

https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/
Educational Institution Information
•

•

Higher Education
• Many experts have been predicting for years that digital course
materials would take off, replacing print textbooks and curricular
supplements as the preferred choice of instructors, students and
institutions alike. But despite growing concerns about the high price of
print textbooks, major investments by states and foundations in open
educational resources (OER), and a big push by commercial publishers
for “inclusive access” programs that make digital course materials
available to all students more affordably, faculty embrace of digital
materials has risen slowly. Until now, it seems. The COVID-19 pandemic
created a breakthrough for digital materials generally and open
educational resources in particular, the latest iteration of an annual report
on faculty use of curricular materials suggests. “Turning Point for Digital
Curricula: Educational Resources in U.S. Higher Education, 2022,” from
Bay View Analytics, finds among other things that the proportion of
instructors who required the use of OER in their courses rose to
22 percent in spring 2022, up from 15 percent in fall 2020, when the last
survey was conducted. The proportion of professors requiring students to
use an inclusive access program in their courses more than doubled, to
19 percent from 8 percent in 2020. Read more at
https://www.insidehighered.com/news/2022/06/30/embrace-digitalcourse-materials-grew-during-pandemic
K-12
• A majority of adults — nearly 70 percent — back a permanent universal
school meal policy, according to a new report by the Urban Institute with
support from the Robert Wood Johnson Foundation. For the past two
years, pandemic-era meal waivers granted by Congress have allowed all
students to eat for free in schools, regardless of their family’s income.
However, that policy will come to a close this fall as the universal school
meal waiver is set to expire today. Now, families who qualify for free and
reduced-price meals will have to apply to be eligible. Read more
at https://www.k12dive.com/news/nearly-70-of-adults-support-permanentextension-of-universal-school-meals/626343/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=
American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
• Governor Kathy Hochul today announced that more than 10.9 million Excelsior Passes
have been issued to date. As the first-in-the-nation platform continues to evolve to meet
New Yorkers' needs, and as the original Excelsior Pass types expire, the State reminds
New Yorkers to retrieve the latest and most robust Pass option available, Excelsior
Pass Plus. "As New Yorkers continue to navigate through these challenging times, our
state continues to lead the nation with bold, transformative solutions," Governor Hochul
said. "New York will continue to utilize digital technology to better meet the needs of the
people we serve. I encourage all New Yorkers who are interested to get their Excelsior
Pass Plus today." Excelsior Pass Plus—the newest and most comprehensive Pass
option—is a secure, digital copy of an individual's COVID-19 vaccination record, which,
as a record, does not expire. Validated by the State of New York and built on open,
interoperable standards now used by more than 23 U.S. states, Puerto Rico, and
Canada, New Yorkers can use their Excelsior Pass Plus in these places and others,
where SMART Health Cards are accepted. The Pass Plus also includes an individual's
booster or additional dose(s), so long as it is retrieved three to four days following
administration. Just like Excelsior Pass, a negative test Pass Plus is also available.
https://www.governor.ny.gov/news/governor-hochul-announces-nearly-11-millionexcelsior-passes-issued-date-reminds-new-yorkers
New York State Department of Health (DOH)
On July 1, 2022, Governor Hochul updated New Yorkers on the state's progress
combating COVID-19. "As New Yorkers travel to spend Fourth of July weekend with family and
friends, I encourage everyone to continue to exercise caution and lean on the tools we know that
protect us from COVID-19," Governor Hochul said. "Getting vaccinated, staying up-to-date on
your boosters, and testing if you're experiencing symptoms, are our best defenses. If you do end
up testing positive, talk to your doctor about available treatments."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progresscombating-covid-19-291
For a list of positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

Connecticut
• Governor Ned Lamont today announced that he has signed a declaration that will enable
crucial federal support Connecticut has been receiving throughout the COVID-19
pandemic – including supplemental food benefits for households in need and noncongregate housing for individuals experiencing homelessness – to continue through
December 28, 2022, or until the federal public health emergency ends, whichever is
earlier. The governor specifically stated in the declaration that he does not intend to
issue any executive orders under this declaration but rather wants to ensure that his
administration has the authorities necessary to apply for and receive federal assistance
in response to the pandemic. “We cannot ignore the reality that the COVID-19 pandemic
has disproportionately impacted low-income families and communities, many of whom
continue to depend on public assistance programs administered by the state,” Governor
Lamont said. “The continuation of this declaration ensures that Connecticut residents
who need additional support during this time will still have access to those resources.”
Having this declaration in place throughout the pandemic has enabled Connecticut
households that are enrolled in the Supplemental Nutrition Assistance Program (SNAP)
to access supplemental, emergency benefits to purchase food. On average, these
supplemental benefits have been providing households an additional $154.74 in food
benefits per month, with all enrolled households receiving at least an additional $95.00
per month. Connecticut has received and distributed $748 million in emergency SNAP
benefits since these additional allotments were first provided by the USDA Food and
Nutrition Service at the onset of the pandemic. https://portal.ct.gov/Office-of-theGovernor/News/Press-Releases/2022/06-2022/Governor-Lamont-Issues-DeclarationEnabling-Crucial-Federal-Support-for-COVID-Response-To-Continue

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
Effective July 1, 2022, the NYC DOHMH will provide free COVID-19 testing and anti-viral pills are
available, beginning July 1, at Test-to-Treat sites around the city. The mobile testing units, managed
by NYC Test & Trace Corps, provide no-cost instant access to antiviral medication (Paxolvid) for
eligible New Yorkers who test positive at the sites. Treatment can prevent severe illness and in many
cases hospitalization.
https://www1.nyc.gov/site/coronavirus/get-tested/covid-19-testing.page#test-kit-pickup
NYC DOHMH launched a new variants data page. The data on this page show how variants of the
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more
severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page

https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page
Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of June 30, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus
Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of July 1, 2022.
https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/
Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of July 1, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of July 1, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
July 1, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.

https://www.gnyha.org/

Every effort is made to provide accurate and complete information in this newsletter.
However, New York Medical College cannot guarantee that there will be no errors. NYMC
makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of
the contents of the newsletters or the articles linked herein and further expressly disclaims
liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice.
Always seek the advice of your physician or other qualified health provider with any questions
you may have regarding a medical condition.
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